“I am incredibly excited to join a firm that has seen so much success and essentially wrote the book on modernising the financial desktop. Annual subscribers get access to all Pellucid publications (Outside the Ropes monthly digital newsletter. Subscribe to the Pellucid Publications Membership for 495/yr. He remained the CEO of Pellucid Analytics, an integrated platform that looks to streamline the formation of investment banking pitch books through data visualisation and customisable content, until the company was acquired in 2019 by a large market data vendor. For our Executive Summary recipients, you can get the rest of the story one of three ways (all can be previewed and purchased at Pellucid’s website (1. Pellucid is built on open source technology MySQL Enterprise housed on Red Hat. The result is plant-derived products that span skincare, wellness, nutraceuticals, athlete recovery and. He has also previously worked as a director at Deutsche Bank. Pellucid data powers the IPRO health care performance report cards and. By combining plant-based pharmaceuticals with innovative plant science and technology, Pellucid Industries aims to provide a world-class growing, selective, processing and distribution centre in Queensland, Australia. Prior to launch Pellucid Analytics, Crockett headed investment banking strats at Credit Suisse and Merrill Lynch, where he oversaw quantitative corporate finance advisory practices and digital transformation projects. However, most professionals agree that Pellucid Marginal Degeneration is a. Often times this condition is confused with Keratoconus and shares many of its characteristics and prognosis. “Adrian was the ideal candidate for us with an exceptional understanding of enabling digital transformation at a macro level as well as deep expertise in end-user ergonomics and application design at a micro level,” said Mazy Dar, CEO of OpenFin. Pellucid Marginal Degeneration or PMD is a bilateral (both eyes), non-inflammatory corneal disease characterized by severe inferior crescent shaped thinning. Overall the patient was happy and noted improved quality of vision.Financial operating system OpenFin has appointed the co-founder of data platform Pellucid Analytics as its chief product officer.Īdrian Crockett has joined OpenFin in New York and will work with the firm’s client base to build the industry’s app infrastructure, as well as lead product development for all offerings. We were able to minimize the glare/halo with the UltraHealth FC. The patient has pellucid degeneration and the lens would decenter slightly inferiorly which resulted in a small amount of residual glare/halo. This fit was more challenging due to the expectations/needs of the patient. Patient was wearing glasses before, and is extremely happy to be in contact lenses that work for most activities. He states he is happy overall, but still has some halos/glare at night. The patient wears the lenses 12-14 hours a day. At this visit the patient preferred a combo of the UH-FC OD and original UH OS because the shadowing was minimized. When the UH-FC lens came in the patient preferred the standard UH, although acuity was equal. Patient wanted to compare glare/halo between the two lenses.

While the cause is unknown, it is believed to. In more severe cases a scarring or a circle may be seen within the cornea. This may result in blurry vision, double vision, nearsightedness, irregular astigmatism, and light sensitivity leading to poor quality-of-life.

He persisted and an UltraHealth-FC was tried OS. Keratoconus (KC) is a disorder of the eye that results in progressive thinning of the cornea. I advised the patient he was doing well and not to change OS. At follow-up the patient was happy OD and wanted to try UltraHealth FC (UH-FC) on his left eye (he was already wearing UltraHealth (UH). Patient stated clarity was great but glare/halo was annoying. The original lens OD, UltraHealth, at follow-up was minimally tight fitting and inferiorly decentered. He feels his vision has improved with the contact lenses. The patient is happy with the acuity and ability to wear contacts. Patient is also in a band and had high visual demands for night driving and dim environments. The patient had corneal cross linking on both eyes and presented needing an improvement to vision for work. The patient is a firefighter/paramedic who was diagnosed with pellucid marginal degeneration OU.

Kristi Rhodes, Schwartz Laser Eye Center, AZ

Pellucid technologies